Blogs

Fran Quigley At first glance, it seems that clinical trials are the much-criticized pharmaceutical industry’s best contribution to the medicines process. The industry leans on governments to fund early-stage research, then claims the patent rights to…

Gina Li The humanitarian crisis in Syria is now in its sixth year. The rest of the world is barraged with alarming images and harrowing accounts of entire families, their homes, and their livelihoods persistently coming under attack. Amidst the…

Marie Elske Gispen The interface between the human rights and drug control frameworks is subject to much international debate and controversy. This is particularly the case in the context of access to controlled medicines: serious negative health,…

Dainius Puras Every year, World Health Day falls on 7 April, the anniversary of the founding of the World Health Organization (WHO). Each year, WHO observes this occasion by promoting an important global health issue. This year, the theme is…

Eric Friedman and Lawrence O. Gostin The need for WHO leadership on human rights—and for global leadership on health and human rights beyond WHO—has always been present, yet has become ever more pressing. A reactionary, nationalist populism has been…

Fran Quigley “OK, but tell us what we would replace it with.” The response in the online comments section following one of my articles on access to medicines may have been a bit curt, but the point was well-taken. Virtually no one who is…